Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study.

导出 OA

翻译打印收藏纠错

作者： Seppo T,Rinne ^[1] ; Laura C,Feemster ^[1] ; Bridget F,Collins ^[1] ; David H,Au ^[1] ; Mark,Perkins ^[2] ; Christopher L,Bryson ^[3] ; Thomas G,O'Riordan ^[4] ; Chuan-Fen,Liu ^[5]

作者单位： Health Services Research and Development, VA Puget Sound Health Care System, Department of Veterans Affairs, 1100 Olive Way Suite 1400, 98104-3801 Seattle, WA, USA ; Department of Pulmonary and Cri Care, University of Washington, Seattle, WA, USA. ^[1] Health Services Research and Development, VA Puget Sound Health Care System, Department of Veterans Affairs, 1100 Olive Way Suite 1400, 98104-3801 Seattle, WA, USA. ^[2] Health Services Research and Development, VA Puget Sound Health Care System, Department of Veterans Affairs, 1100 Olive Way Suite 1400, 98104-3801 Seattle, WA, USA ; Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, USA. ^[3] Gilead Sciences, Inc., Seattle, WA, USA. ^[4] Health Services Research and Development, VA Puget Sound Health Care System, Department of Veterans Affairs, 1100 Olive Way Suite 1400, 98104-3801 Seattle, WA, USA ; Department of Health Services, University of Washington, Seattle, WA, USA. ^[5]

关键词 Asthma Cohort study Glitazones Peroxisome proliferator-activated receptors Thiazolidinediones

DOI 10.1186/1710-1492-10-34

PMID 25024717

发布时间 2024-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交